DOCK4, a GTPase activator, is disrupted during tumorigenesis

Area of Science:

• Genetics
• Molecular Biology
• Cancer Research

Background:

• Tumorigenesis involves genetic alterations, including genomic deletions, that drive cancer progression.
• The CDM gene family encodes regulators of small GTPases, crucial for cellular processes.
• DOCK4, a CDM family member, is implicated in regulating cell adhesion and GTPase activity.

Purpose of the Study:

• To identify genomic deletions selected during tumor progression in a mouse model.
• To investigate the role of the DOCK4 gene in tumorigenesis and cell junction formation.

Main Methods:

• Representational difference analysis was used to identify homozygous genomic deletions in mouse tumor models.
• Functional assays in cell lines and in vivo models were employed to assess DOCK4 activity.
• Complementation assays in C. elegans were performed to evaluate DOCK4 function.

Main Results:

• A homozygous deletion targeting DOCK4 was identified during tumor progression in mouse models.
• DOCK4 activates Rap GTPase, enhancing adherens junction formation.
• Mutant DOCK4, found in human cancers, is defective in Rap1 activation and fails to rescue cellular defects in model organisms.
• Expression of wild-type DOCK4 suppresses anchorage-independent growth and invasion in mouse cancer cells.

Conclusions:

• DOCK4 is a critical regulator of intercellular junctions and a tumor suppressor.
• Disruption of DOCK4 through genomic deletions or mutations contributes to cancer development.
• DOCK4's function in cell adhesion and its inactivation in cancer highlight its therapeutic relevance.